Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Scott A. McLean is active.

Publication


Featured researches published by Scott A. McLean.


Journal of Clinical Oncology | 2011

Features Predicting Sentinel Lymph Node Positivity in Merkel Cell Carcinoma

Jennifer L. Schwartz; Kent A. Griffith; Lori Lowe; Sandra L. Wong; Scott A. McLean; Douglas R. Fullen; Christopher D. Lao; James A. Hayman; Carol R. Bradford; Riley S. Rees; Timothy M. Johnson; Christopher K. Bichakjian

PURPOSE Merkel cell carcinoma (MCC) is a relatively rare, potentially aggressive cutaneous malignancy. We examined the clinical and histologic features of primary MCC that may correlate with the probability of a positive sentinel lymph node (SLN). METHODS Ninety-five patients with MCC who underwent SLN biopsy at the University of Michigan were identified. SLN biopsy was performed on 97 primary tumors, and an SLN was identified in 93 instances. These were reviewed for clinical and histologic features and associated SLN positivity. Univariate associations between these characteristics and a positive SLN were tested for by using either the χ(2) or the Fishers exact test. A backward elimination algorithm was used to help create a best multiple variable model to explain a positive SLN. RESULTS SLN positivity was significantly associated with the clinical size of the lesion, greatest horizontal histologic dimension, tumor thickness, mitotic rate, and histologic growth pattern. Two competing multivariate models were generated to predict a positive SLN. The histologic growth pattern was present in both models and combined with either tumor thickness or mitotic rate. CONCLUSION Increasing clinical size, increasing tumor thickness, increasing mitotic rate, and infiltrative tumor growth pattern were significantly associated with a greater likelihood of a positive SLN. By using the growth pattern and tumor thickness model, no subgroup of patients was predicted to have a lower than 15% to 20% likelihood of a positive SLN. This suggests that all patients presenting with MCC without clinical evidence of regional lymph node disease should be considered for SLN biopsy.


International Journal of Radiation Oncology Biology Physics | 2009

Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.

Farzan Siddiqui; Mehul Patel; Mumtaz J. Khan; Scott A. McLean; Jadranka Dragovic; Jian Yue Jin; Benjamin Movsas; Samuel Ryu

PURPOSE To determine the feasibility, safety, and efficacy of stereotactic body radiation therapy (SBRT), also known as radiosurgery, in patients with head-and-neck cancers. METHODS AND MATERIALS Patients with pathologically proven malignant lesions in the head-and-neck region were treated using single-dose SBRT (S-SBRT) or fractionated SBRT (F-SBRT). Radiation doses were either single-fraction 13-18 Gy for S-SBRT or 36-48 Gy in five to eight fractions for F-SBRT. Response evaluation was based on clinical examinations and computed tomography/magnetic resonance imaging scans. Pre- and post-SBRT tumor dimensions were measured in three axes, and tumor volumes were calculated. Response evaluation also was performed using World Health Organization criteria. RESULTS Fifty-five lesions were treated in 44 patients (25 men, 19 women). There were three groups of patients: those with primary (n = 10), recurrent (n = 21), and metastatic tumors (n = 13). The predominant histologic type was squamous cell carcinoma (n = 33). The majority of lesions were treated using F-SBRT (n = 37). Based on radiographic and clinical assessment, a 77% (complete + partial response) response rate was noted. Percentage of reduction in tumor volume was 52% +/- 38% based on follow-up scans in 24 patients. Tumor control rates at 1 year were 83.3% and 60.6% in the primary and recurrent groups, respectively. Median overall survival was 28.7, 6.7, and 5.6 months for the primary, recurrent, and metastatic groups, respectively. Radiation Therapy Oncology Group Grade 1-2 mucositis was noted in all patients treated for oropharyngeal or laryngeal lesions. CONCLUSIONS The SBRT in single or fractionated doses offers a viable treatment option for selected patients with primary, recurrent, and metastatic head-and-neck cancers with functional preservation.


Journal of The American College of Surgeons | 2012

Lean Management in Academic Surgery

Ryan M. Collar; Andrew G. Shuman; Sandra Feiner; Amy K. McGonegal; Natalie Heidel; Mary Duck; Scott A. McLean; John E. Billi; David W. Healy; Carol R. Bradford

BACKGROUND Lean is a management system designed to enhance productivity by eliminating waste. Surgical practice offers many opportunities for improving efficiency. Our objective was to determine whether systematic implementation of lean thinking in an academic otolaryngology operating room improves efficiency and profitability and preserves team morale and educational opportunities. STUDY DESIGN In an 18-month prospective quasi-experimental study, a multidisciplinary task force systematically implemented lean thinking within an otolaryngology operating room of an academic health system. Operating room turnover time and turnaround time were measured during a baseline period; an observer-effect period in which workers were made aware that their efficiency was being measured but before implementing lean changes; and an intervention period after redesign principles had been used. The impact on teamwork, morale, and surgical resident education were measured during the baseline and intervention periods through validated surveys. A profit model was applied to estimate the financial implications of the study. RESULTS There was no difference between the baseline and observer-effect periods of the study for turnover time (p = 0.98) or turnaround time (p = 0.20). During the intervention period, the mean turnover time and turnaround time were significantly shorter than during the baseline period (29 vs 38 minutes; p < 0.001 and 69 vs 89 minutes; p < 0.001, respectively). The composite morale score suggested improved morale after implementation (p = 0.011). Educational metrics were unchanged before and after implementation. The annual opportunity revenue for the involved operating room is


Cancer | 2012

Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma

Audrey B. Erman; Ryan M. Collar; Kent A. Griffith; Lori Lowe; Michael S. Sabel; Christopher K. Bichakjian; Sandra L. Wong; Scott A. McLean; Riley S. Rees; Timothy M. Johnson; Carol R. Bradford

330,000; when extrapolated throughout the operating rooms, lean thinking could create 6,500 hours of capacity annually. CONCLUSIONS Application of lean management techniques to a single operating room and surgical service improved operating room efficiency and morale, sustained resident education, and can provide considerable financial gains when scaled to an entire academic surgical suite.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2014

Aspiration pneumonia after chemo-intensity-modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia-related predictors.

Klaudia U. Hunter; Oliver E. Lee; Teresa H. Lyden; Marc J. Haxer; Felix Y. Feng; Mathew Schipper; Francis P. Worden; Mark E. Prince; Scott A. McLean; Gregory T. Wolf; Carol R. Bradford; Douglas B. Chepeha; Avraham Eisbruch

Sentinel lymph node biopsy (SLNB) has emerged as a widely used staging procedure for cutaneous melanoma. However, debate remains around the accuracy and prognostic implications of SLNB for cutaneous melanoma arising in the head and neck, as previous reports have demonstrated inferior results to those in nonhead and neck regions. Through the largest single‐institution series of head and neck melanoma patients, the authors set out to demonstrate that SLNB accuracy and prognostic value in the head and neck region are comparable to other sites.


Laryngoscope | 2010

Predictors of poor sleep quality among head and neck cancer patients

Andrew G. Shuman; Sonia A. Duffy; David L. Ronis; Susan L. Garetz; Scott A. McLean; Karen E. Fowler; Jeffrey E. Terrell

The purpose of this study was to assess aspiration pneumonia (AsPn) rates and predictors after chemo‐irradiation for head and neck cancer.


Laryngoscope | 2012

Diagnostic modalities for distant metastasis in head and neck squamous cell carcinoma: are we changing life expectancy?

Matthew E. Spector; Steven B. Chinn; Andrew J. Rosko; Francis P. Worden; P. Daniel Ward; Vasu Divi; Scott A. McLean; Jeffrey S. Moyer; Mark E. Prince; Gregory T. Wolf; Douglas B. Chepeha; Carol R. Bradford

The objective of this study was to determine the predictors of sleep quality among head and neck cancer patients 1 year after diagnosis.


PLOS ONE | 2016

Socioeconomic and Other Demographic Disparities Predicting Survival among Head and Neck Cancer Patients.

Seung Hee Choi; Jeffrey E. Terrell; Karen E. Fowler; Scott A. McLean; Tamer Ghanem; Gregory T. Wolf; Carol R. Bradford; Jeremy M. G. Taylor; Sonia A. Duffy

To determine if the various imaging modalities for distant metastasis (DM) diagnosis alters life expectancy in head and neck squamous cell carcinoma (HNSCC).


Oral Oncology | 2013

Characterization of tumorigenic cell lines from the recurrence and lymph node metastasis of a human salivary mucoepidermoid carcinoma

Kristy A. Warner; April Adams; Lisiane Bernardi; Carolina Nor; Kelsey A. Finkel; Zhaocheng Zhang; Scott A. McLean; Joseph I. Helman; Gregory T. Wolf; Vasu Divi; Lurdes Queimado; Frederic J. Kaye; Rogerio M. Castilho; Jacques E. Nör

Background The Institute of Medicine (IOM) report, “Unequal Treatment,” which defines disparities as racially based, indicates that disparities in cancer diagnosis and treatment are less clear. While a number of studies have acknowledged cancer disparities, they have limitations of retrospective nature, small sample sizes, inability to control for covariates, and measurement errors. Objective The purpose of this study was to examine disparities as predictors of survival among newly diagnosed head and neck cancer patients recruited from 3 hospitals in Michigan, USA, while controlling for a number of covariates (health behaviors, medical comorbidities, and treatment modality). Methods Longitudinal data were collected from newly diagnosed head and neck cancer patients (N = 634). The independent variables were median household income, education, race, age, sex, and marital status. The outcome variables were overall, cancer-specific, and disease-free survival censored at 5 years. Kaplan-Meier curves and univariate and multivariate Cox proportional hazards models were performed to examine demographic disparities in relation to survival. Results Five-year overall, cancer-specific, and disease-free survival were 65.4% (407/622), 76.4% (487/622), and 67.0% (427/622), respectively. Lower income (HR, 1.5; 95% CI, 1.1–2.0 for overall survival; HR, 1.4; 95% CI, 1.0–1.9 for cancer-specific survival), high school education or less (HR, 1.4; 95% CI, 1.1–1.9 for overall survival; HR, 1.4; 95% CI, 1.1–1.9 for cancer-specific survival), and older age in decades (HR, 1.4; 95% CI, 1.2–1.7 for overall survival; HR, 1.2; 95% CI, 1.1–1.4 for cancer-specific survival) decreased both overall and disease-free survival rates. A high school education or less (HR, 1.4; 95% CI, 1.0–2.1) and advanced age (HR, 1.3; 95% CI, 1.1–1.6) were significant independent predictors of poor cancer-specific survival. Conclusion Low income, low education, and advanced age predicted poor survival while controlling for a number of covariates (health behaviors, medical comorbidities, and treatment modality). Recommendations from the Institute of Medicine’s Report to reduce disparities need to be implemented in treating head and neck cancer patients.


Applied Immunohistochemistry & Molecular Morphology | 2011

Immunophenotypic heterogeneity of primary sinonasal melanoma with aberrant expression of neuroendocrine markers and calponin.

Hwajeong Lee; Frank X. Torres; Scott A. McLean; Ruey Chen; Min W. Lee

UNLABELLED The long-term outcome of patients with mucoepidermoid carcinoma is poor. Limited availability of cell lines and lack of xenograft models is considered a major barrier to improved mechanistic understanding of this disease and development of effective therapies. OBJECTIVE To generate and characterize human mucoepidermoid carcinoma cell lines and xenograft models suitable for mechanistic and translational studies. METHODS Five human mucoepidermoid carcinoma specimens were available for generation of cell lines. Cell line tumorigenic potential was assessed by transplantation and serial in vivo passaging in immunodeficient mice, and cell line authenticity verified by short tandem repeat (STR) profiling. RESULTS A unique pair of mucoepidermoid carcinoma cell lines was established from a local recurrence (UM-HMC-3A) and from the metastatic lymph node (UM-HMC-3B) of the same patient, 4 years after surgical removal of the primary tumor. These cell lines retained epithelial-like morphology through 100 passages in vitro, contain the Crtc1-Maml2 fusion oncogene (characteristic of mucoepidermoid carcinomas), and express the prototypic target of this fusion (NR4A2). Both cell lines generated xenograft tumors when transplanted into immunodeficient mice. Notably, the xenografts exhibited histological features and Periodic Acid Schiff (PAS) staining patterns that closely resembled those found in human tumors. STR profiling confirmed the origin and authenticity of these cell lines. CONCLUSION These data demonstrate the generation and characterization of a pair of tumorigenic salivary mucoepidermoid carcinoma cell lines representative of recurrence and lymph node metastasis. Such models are useful for mechanistic and translational studies that might contribute to the discovery of new therapies for mucoepidermoid carcinoma.

Collaboration


Dive into the Scott A. McLean's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge